Search

An international study will investigate the effect of a third dose of vaccine against mpox. The EU-funded project involves researchers from universities and clinics in Sweden, Belgium, France, and Ireland, and is coordinated by the Public Health Agency of Sweden.

The Mpox Booster Trial investigates whether a booster dose of the MVA-BN vaccine improves immune protection against mpox and is safe. Here you can find the trial’s aims, design, partners, and further information.

As of 2013, national vaccination programmes are regulated by the Communicable Diseases Act.

Changes to the national vaccination programmes are made following a regulated, defined and open process.